GSK PLC closed 21.63% short of its 52-week high of £18.24, which the company reached on May 16th.

GSK PLC closed 20.87% below its 52-week high of £18.24, which the company reached on May 16th.

The world’s most profitable hedge fund has started betting against shares in GSK (GSK), the first significant short on the FTSE 100 drugmaker’s ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

Strong performances by AstraZeneca and mining stocks today helped the FTSE 100 index set a new record above 8700. The rise of 1% came as the Bank of England prepared to announce another interest ...

AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue overhanging shares: an investigation of a top executive by authorities in China, one ...

UK's FTSE 100 firmed on Wednesday after two straight days of losses, buoyed by gains in shares of heavyweight GSK and gold miners, while investors turned their focus to the Bank of England's rate ...

London’s FTSE 100 was up 0.4% at 8,604.03 in afternoon trade on Wednesday. Pharma giant GSK surged to the top of the index as it missed forecasts slightly with its annual results, but raised its ...

GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. Last quarter, its operating ...

Full-year net profit climbed 21% to 100.99 billion Danish kroner, also beating estimates of 99.14 billion Danish kroner for 2024. British pharmaceutical giant GSK raised its long-term sales guidance ...